Results 71 to 80 of about 2,195 (134)

Gaucher’s Disease – current state of knowledge and future perspectives?

open access: yesJournal of Education, Health and Sport
Introduction and purpose: Gaucher's Disease (GD), a rare genetic disorder, is a difficult challenge in genetic and metabolic disorders. The aim of this review is to provide an exploration of GD, spanning its pathophysiology to the latest advancements in
Katarzyna Szymańska   +7 more
doaj   +1 more source

Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes). [PDF]

open access: yesMol Brain, 2021
Nakanishi E   +10 more
europepmc   +1 more source

Macitentan in the treatment of pulmonary hypertension in Gaucher‚s disease. [PDF]

open access: yesAnatol J Cardiol, 2020
Taylan G   +3 more
europepmc   +1 more source

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease

open access: yesTranslational Neurodegeneration
Parkinson’s disease (PD) is the second most common neurodegenerative disease. The development of PD is closely linked to genetic and environmental factors, with GBA1 variants being the most common genetic risk.
Xuxiang Zhang   +3 more
doaj   +1 more source

Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease. [PDF]

open access: yesOrphanet J Rare Dis, 2020
Andrade-Campos MM   +9 more
europepmc   +1 more source

Beta Thalassemia Major with Gaucher's Disease: A Rare Entity. [PDF]

open access: yesCureus, 2019
Bai N   +4 more
europepmc   +1 more source

Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher's disease. [PDF]

open access: yesJ Orthop Surg Res, 2019
Roca-Espiau M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy